Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Emerging Platform Trials for the Treatment of Newly Diagnosed and Recurrent Glioblastoma. Local targets link to admitted publications; unresolved targets remain external evidence.
The 2021 WHO classification of tumors of the central nervous system: a summary
10.1093/neuonc/noab106 · 2021 · External reference
Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma
10.1158/1078-0432.ccr-20-3805 · 2021 · External reference
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
10.1056/nejmoa043330 · 2005 · External reference
MGMT gene silencing and benefit from temozolomide in glioblastoma
10.1056/nejmoa043331 · 2005 · External reference
Unresolved reference
External reference
Broad applicability of the goldspire™ platform for the treatment of solid tumors
10.1016/j.clim.2024.110373 · 2024 · External reference
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients
10.2217/fon-2023-0702 · 2024 · External reference
Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
10.1200/jco.2001.19.8.2189 · 2001 · External reference
Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax® platform in the treatment of glioblastoma multiforme
10.2217/cns.14.54 · 2015 · External reference
Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial
10.1001/jamaoncol.2022.5370 · 2023 · External reference
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
10.1038/s41591-024-02893-z · 2024 · External reference
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
10.1016/j.ebiom.2019.08.030 · 2019 · External reference
CAR T cell therapy for glioblastoma: a review of the first decade of clinical trials
10.1016/j.ymthe.2025.03.004 · 2025 · External reference
Unresolved reference
External reference
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
10.1038/s41467-024-45818-7 · 2024 · External reference
Unresolved reference
External reference
